• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Monday, April 22, 2024

    Time

    9:00 PM - 10:15 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.25 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      It has been over 40 years since “HIV” and “AIDS” became commonplace words for both the healthcare profession and the general population. Fortunately, in the 1990s, drugs with different mechanisms of action were developed to take HIV from a “death sentence” to a manageable disease. Today, the focus for affected individuals has shifted to medication adherence for these robust therapies, as well as disease prevention. PrEP (Pre-Exposure Prophylaxis) is a priority now that we have preventative agents that are more patient-friendly, to help bring an end to the spread of this disease. Join Professor Pete for a comprehensive discussion of the history, treatment, and preventative strategies for HIV and AIDS as patient care moves into a new era.

      This course meets the FL requirement of 1.0 board-approved contact hour on the topic of HIV/AIDS.




      Handouts

      Slide Document 23209L02_2pp.pdf
      Slide Document 23209L02_6pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Describe the pharmacist’s critical role in counseling and educating HIV patients to improve the patient outcomes and medication adherence, as well as medical retention, in the healthcare system
      Categorize antiretroviral therapy (ARV) for HIV to include the eight categories of HIV medications and their mechanisms of action, efficacy, dosing, safety and tolerability profiles, and first-line combination therapy
      State the current Florida Law on AIDS and its impact on testing, confidentiality of test results, and treatment, including the offering of HIV testing to pregnant women and partner notification issues pursuant to Sections 381.004 and 384.25
      Identify the modes of transmission for HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker
      Discuss the role of Pre-Exposure Prophylaxis and appropriate patient selection
      Recognize the epidemiology, prevention, and appropriate clinical management of HIV
      Identify related infections associated with HIV, including tuberculosis (TB)

      Pharmacy Technician

      Describe the pharmacist’s critical role in counseling and educating HIV patients to improve the patient outcomes and medication adherence, as well as medical retention, in the healthcare system
      Categorize antiretroviral therapy (ARV) for HIV to include the eight categories of HIV medications and their mechanisms of action, efficacy, dosing, safety and tolerability profiles, and first-line combination therapy
      State the current Florida Law on AIDS and its impact on testing, confidentiality of test results, and treatment, including the offering of HIV testing to pregnant women and partner notification issues pursuant to Sections 381.004 and 384.25
      Identify the modes of transmission for HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker
      Discuss the role of Pre-Exposure Prophylaxis and appropriate patient selection
      Recognize the epidemiology, prevention, and appropriate clinical management of HIV
      Identify related infections associated with HIV, including tuberculosis (TB)

      Nurse

      Describe the pharmacist’s critical role in counseling and educating HIV patients to improve the patient outcomes and medication adherence, as well as medical retention, in the healthcare system
      Categorize antiretroviral therapy (ARV) for HIV to include the eight categories of HIV medications and their mechanisms of action, efficacy, dosing, safety and tolerability profiles, and first-line combination therapy
      State the current Florida Law on AIDS and its impact on testing, confidentiality of test results, and treatment, including the offering of HIV testing to pregnant women and partner notification issues pursuant to Sections 381.004 and 384.25
      Identify the modes of transmission for HIV, including transmission from a healthcare worker to a patient and the patient to the healthcare worker
      Discuss the role of Pre-Exposure Prophylaxis and appropriate patient selection
      Recognize the epidemiology, prevention, and appropriate clinical management of HIV
      Identify related infections associated with HIV, including tuberculosis (TB)
    • Repeat Presentation

      This presentation was last given on 4/22/2024 9:00 PM

      Future Airings

      Date Time
      Monday, May 13, 2024 9:00 PM View
      Tuesday, June 25, 2024 8:00 PM View

    • Activity Type

      Knowledge

      CE Broker

      20-1081838

      Universal Activity Number

      Pharmacist 0798-0000-23-209-L02-P

      Pharmacy Technician 0798-0000-23-209-L02-T

      Nurse 0798-0000-23-209-L02-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

    • Faculty

      Peter  Kreckel, RPh
      Retired Adjunct Assistant Professor, Saint Francis University

    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.